GYRE EBITDA Margin
Gyre Therapeutics Inc · EBITDA Margin
GYRE EBITDA Margin
Latest reported-10.56%period ending
GYRE EBITDA Margin (-513.86% → -10.56%)
Annual ebitda margin
High-resolution chart · PNG
GYRE ebitda margin history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| 14.5101% | |
| 16.8471% | |
| 17.9171% | |
| 10.305% | |
| -1,194.3718% | |
| -267.8203% | |
| 0% | |
| -563,700% | |
| -2,126.6208% | |
| -5,019.7995% | |
| -732.2286% | |
| -376.6685% | |
| -1,288.5643% | |
| -4.5766% | |
| -7.4408% | |
| 17.6309% | |
| -153.5791% | |
| -131.1626% | |
| -266.6258% | |
| 1.5151% | |
| -2,469.4729% | |
| -618.6194% | |
| -816.2734% | |
| -918.7664% | |
| -513.8579% |